China · Delayed Price · Currency is CNY ChengDa Pharmaceuticals Statistics
Total Valuation
SHE:301201 has a market cap or net worth of CNY 3.52 billion. The enterprise value is 2.65 billion.
| Market Cap | 3.52B |
| Enterprise Value | 2.65B |
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Jul 15, 2026 |
Share Statistics
SHE:301201 has 151.47 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 151.47M |
| Shares Outstanding | 151.47M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | 40.64% |
| Owned by Institutions (%) | 2.46% |
| Float | 80.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.39 |
| PB Ratio | 1.72 |
| P/TBV Ratio | 1.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 113.83 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.55 |
| EV / EBITDA | 49.03 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.55, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.55 |
| Quick Ratio | 4.64 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.96 |
| Debt / FCF | n/a |
| Interest Coverage | -24.80 |
Financial Efficiency
Return on equity (ROE) is -1.97% and return on invested capital (ROIC) is -3.32%.
| Return on Equity (ROE) | -1.97% |
| Return on Assets (ROA) | -1.00% |
| Return on Invested Capital (ROIC) | -3.32% |
| Return on Capital Employed (ROCE) | -1.78% |
| Weighted Average Cost of Capital (WACC) | 4.02% |
| Revenue Per Employee | 687,266 |
| Profits Per Employee | -59,260 |
| Employee Count | 694 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 2.26 |
Taxes
| Income Tax | -2.61M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.21% in the last 52 weeks. The beta is -0.04, so SHE:301201's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | -35.21% |
| 50-Day Moving Average | 29.23 |
| 200-Day Moving Average | 36.70 |
| Relative Strength Index (RSI) | 35.81 |
| Average Volume (20 Days) | 4,322,623 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301201 had revenue of CNY 476.96 million and -41.13 million in losses. Loss per share was -0.27.
| Revenue | 476.96M |
| Gross Profit | 114.87M |
| Operating Income | -37.51M |
| Pretax Income | -43.85M |
| Net Income | -41.13M |
| EBITDA | 54.00M |
| EBIT | -37.51M |
| Loss Per Share | -0.27 |
Balance Sheet
The company has 929.89 million in cash and 51.73 million in debt, with a net cash position of 878.17 million or 5.80 per share.
| Cash & Cash Equivalents | 929.89M |
| Total Debt | 51.73M |
| Net Cash | 878.17M |
| Net Cash Per Share | 5.80 |
| Equity (Book Value) | 2.05B |
| Book Value Per Share | 13.55 |
| Working Capital | 1.02B |
Cash Flow
In the last 12 months, operating cash flow was 30.95 million and capital expenditures -60.85 million, giving a free cash flow of -29.90 million.
| Operating Cash Flow | 30.95M |
| Capital Expenditures | -60.85M |
| Depreciation & Amortization | 91.52M |
| Net Borrowing | -6.52M |
| Free Cash Flow | -29.90M |
| FCF Per Share | -0.20 |
Margins
Gross margin is 24.08%, with operating and profit margins of -7.87% and -8.62%.
| Gross Margin | 24.08% |
| Operating Margin | -7.87% |
| Pretax Margin | -9.19% |
| Profit Margin | -8.62% |
| EBITDA Margin | 11.32% |
| EBIT Margin | -7.87% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.86%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.86% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.05% |
| Shareholder Yield | 0.81% |
| Earnings Yield | -1.17% |
| FCF Yield | -0.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on July 7, 2023. It was a forward split with a ratio of 1.6.
| Last Split Date | Jul 7, 2023 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
SHE:301201 has an Altman Z-Score of 13.71 and a Piotroski F-Score of 4.
| Altman Z-Score | 13.71 |
| Piotroski F-Score | 4 |